文献速递中医妇科中药与中成药合理使用

苦参凝胶联合抗真菌药物治疗外阴阴道假丝酵母菌病的系统评价与Meta分析

Kushen Gel combined with antifungal drugs for the treatment of vulvovaginal candidiasis: A systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · J Ethnopharmacol · 2024-11-16

该系统评价与Meta分析纳入42项RCT共4259例VVC患者,比较苦参凝胶联合抗真菌药与单用抗真菌药。结果显示联合治疗提高总有效率(RR=1.20,95%CI[1.17,1.23],P<0.00001)、降低复发率(RR=0.21,95%CI[0.13,0.34],P<0.00001),安全性无显著差异(RR=0.56,95%CI[0.30,1.03],P=0.11),但纳入研究方法学质量较差。

要点

  • 苦参凝胶联合抗真菌药可提高VVC总有效率(RR=1.20)。
  • 联合治疗可显著降低VVC复发率(RR=0.21)。
  • 安全性无显著差异,但证据质量受方法学限制。

核心结论

  • 苦参凝胶联合抗真菌药可能提高VVC治疗有效性并降低复发率,但需更多高质量大样本研究证实。

研究设计与样本

  • 系统评价与Meta分析,检索CNKI、万方、维普、CBM、PubMed、Cochrane Library和Embase至2024年1月,纳入42项RCT共4259例VVC患者,采用RoB 1.0评估质量,RevMan 5.4分析。

主要发现

  • 联合治疗较单用抗真菌药提高总有效率(RR=1.20,95%CI[1.17,1.23],P<0.00001)。
  • 联合治疗降低复发率(RR=0.21,95%CI[0.13,0.34],P<0.00001)。
  • 安全性无显著差异(RR=0.56,95%CI[0.30,1.03],P=0.11)。

关键数值与推荐

  • 主要结局为总有效率和复发率,次要结局为不良事件和临床症状缓解时间。
  • 总有效率RR=1.20(95%CI[1.17,1.23],P<0.00001)。
  • 复发率RR=0.21(95%CI[0.13,0.34],P<0.00001)。
  • 不良事件RR=0.56(95%CI[0.30,1.03],P=0.11)。

临床怎么用

  • 在临床中可考虑苦参凝胶联合抗真菌药治疗VVC以可能提高疗效并减少复发。
  • 联合用药时仍需关注安全性,尽管Meta分析未显示不良事件显著增加。
  • 应结合患者具体情况和证据质量谨慎决策,并告知患者证据局限性。

局限性

  • 纳入研究方法学质量较差,可能影响结论可靠性。
  • 需要更多大样本、设计良好的高质量研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Vulvovaginal candidiasis (VVC) represents the most prevalent form of candidal infections, imposing a significant societal burden. Kushen gel, a chinese patent medicine, has demonstrated favorable outcomes in the treatment of VVC. In clinical practice, Kushen gel is often used in conjunction with antifungal drugs. However, the clinical evidence supporting the combined use of Kushen gel with antifungal drugs for the treatment of VVC is currently limited. AIM OF THE STUDY: This study aimed to evaluate the effectiveness and safety of Kushen gel combined with antifungal drugs in the treatment of vulvovaginal candidiasis (VVC). MATERIALS AND METHODS: Databases namely CNKI, Wanfang Database, VIP Database, CBM, PubMed, Cochrane Library, and Embase were searched from their inception to January 2024. Randomized controlled trials (RCTs) applying Kushen gel combined with antifungal drugs for the treatment of VVC were included. Methodological quality assessment was performed using the Cochrane risk of bias assessment tool (RoB 1.0). A Meta-analysis was performed using RevMan 5.4 software. The primary outcomes were total efficacy rate, recurrence rate, secondary outcomes included adverse events and time to clinical symptom resolution. RESULTS: A Meta-analysis of 42 RCTs, encompassing a total of 4259 VVC patients was conducted. The results indicated that compared to antifungal drugs alone, Kushen gel combined with antifungal drugs increased the effectiveness (RR = 1.20, 95%CI [1.17, 1.23], P < 0.00001) and reduced the recurrence rate (RR = 0.21, 95%CI [0.13, 0.34], P < 0.00001), with no significant difference in safety (RR = 0.56, 95%CI [0.30, 1.03], P = 0.11). CONCLUSIONS: Based on the available results, it appears that the combination of Kushen gel with antifungal drugs may increase the effectiveness and reduce the recurrence rate. However, due to the poor methodological quality of the included studies, more high-quality evidence from large-sample and well-designed research is needed in the future.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Yu F, Zhang L, Zhang X, et al. Kushen Gel combined with antifungal drugs for the treatment of vulvovaginal candidiasis: A systematic review and meta-analysis of randomized controlled trials. J Ethnopharmacol. 2024. PMID: 39557104. doi:10.1016/j.jep.2024.119107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。